M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma

ConclusionCompared with M1, M2 macrophages can inhibit the anti-tumor effect of Lenvatinib on cholangiocarcinoma through immune regulation, which may be related to the tumor angiogenesis factor effect of M2 macrophage.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research